You're In! See you on August 12th
You’ve registered for From SSRIs to Psychedelics: What Happens In Between with Dr. Dave Rabin and Paul F. Austin. Your access details are on their way to your inbox now.
Wednesday, August 12th at 1 PM / 4 PM ET
Important next steps:
1. Mark Your Calendar
Pro tip: Set a reminder for 10 minutes before to ensure you’re ready to join.
2. Watch Your Inbox
We’ve sent your webinar access details to your registered email address.
If you don’t see it within the next 15 minutes, please check your spam folder.
Take a moment to reflect on:
- Think of a client who came to you already medicated. What did you tell them? What do you wish you’d been able to tell them?
- Have you watched a taper go badly, yours or someone else’s? What was the first sign, and did anyone read it correctly at the time?
- If a client asked you tomorrow why psychedelics and SSRIs don’t mix, what would you actually say?
- Where does your scope end here? Could you say it in one sentence, to a client or to a prescriber?
Your reflections will connect the protocol to clients already sitting in your practice, and give you sharper questions for the Q&A.
Want to Dive Deeper?
Deepen your understanding of SSRIs & psychedelics with these curated resources that complement what you’ll learn at the training:
Microdosing on SSRIs? A Psychiatrist’s Take
Paul F. Austin and Dr. Dave Rabin on microdosing, SSRIs, and why the taper comes first. Dr. Rabin lays out the interaction risk and the ketamine bridge in his own words.
SSRIs vs. Psychedelics: From Blunting to Rebooting
Paul F. Austin and Dr. Robin Carhart-Harris on what the head-to-head trial against escitalopram actually showed, and why a researcher with nothing to sell is skeptical of the “stay on your SSRI” position.
Remember: live attendees receive “From SSRIs to Psychedelic Medicine: A Clinical Primer for Practitioners” and can ask Dr. Rabin questions during the Q&A.
